Neuronetics Announces Expanded TMS Access through United HealthCare
MALVERN, Pa., April 28, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that United HealthCare has updated their Medicare Advantage policy in states covered by National Government Services (NGS) Medicare.
Related news for (STIM)
- Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
- Neuronetics Reports First Quarter 2025 Financial and Operating Results
- Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/04/25 01:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/04/25 12:00 PM